C4 Therapeutics Files $400M Shelf Offering for Mixed Securities

viernes, 21 de noviembre de 2025, 5:17 pm ET1 min de lectura
CCCC--

C4 Therapeutics has filed a shelf registration to offer up to $400M in securities, which may include common stock, preferred stock, debt securities, warrants, or units in one or more combinations and tranches. This offering will enable the company to raise capital for various purposes, including general corporate purposes, research and development, and strategic transactions.

C4 Therapeutics Files $400M Shelf Offering for Mixed Securities

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios